Course Schedule: Pharmacotherapy II Spring 2011 Revised 12/6/2010
|
|
|
- Corey Daniels
- 5 years ago
- Views:
Transcription
1 Course Schedule: Pharmacotherapy II Spring 2011 Revised 12/6/2010 All lectures will be held from 9:05-11:00 am Monday and Wednesday, as well as 10:10-11:00 am Friday in room MoosT and LS 163 (), unless otherwise indicated. Bolded lecturer denotes the provider of the lecture versus faculty colleague in attendance at alternate campus. DATE LECTURE TOPIC Jan. 19 (W) Orientation and Course Overview CV: The CV Continuum Jan. 21 (F) CV: Hypertension I Required Readings: 1. JNC 7 Prevention, Detection, Evaluation and Treatment of High Blood Pressure- Link found on course 2. Rosendorff Circulation 2007;115: Jan. 22 (Sat) Jan. 24 (M) 3. Additional portions of selected studies, TBA Multiple Choice Question Group Project: Deadline to indicate topic preference - after 11AM topics will be assigned randomly. CV: Hypertension II CV: Hypertension III Jan. 26 (W) CV: Hypertension IV Multiple Choice Question Group Project: Topic, group and reviewer assignments distributed. Be SURE you are in a group CV: Hyperlipidemia-Drug Pathophysiology Jan. 27 (Th) Quiz 1 (HTN) due by 8:00 am 01/28/10 Jan. 28 (F) CV: Hyperlipidemia-Drug Therapy I Required Readings: 1.Executive Summary of the Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) 2. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines (White Paper) Grundy Circulation 2004;110: Diagnosis and Management of the Metabolic Syndrome: Grundy Circulation 2005;112: Jan. 31 (M) DiPiro: Chapter 23: Hyperlipidemia CV: Hyperlipidemia-Drug Therapy II CV: Hyperlipidemia-Drug Therapy III
2 DATE LECTURE TOPIC Feb. 1 (T) Quiz 2 (Lipids) due by 8:00 am 02/02/10 Feb. 2 (W) CV: Review and Case Studies for HTN and Hyperlipidemia CV: ASA and Primary Prevention of CVD Feb. 3 (Th) Pre-exam review for CV Exam #1 (optional) Feb. 4 (F) CV Exam #1 Feb. 7 (M) CV: Introduction to Ischemic Heart Disease DiPiro: Chaper 17: Ischemic Heart Disease 1. ACC/AHA 2002 Guideline Update for the Management of Patients with Chronic Stable Angina-Full Text. Link found on course Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the Management of Patients With Chronic Stable Angina. Link found on course CV: Pharmacotherapy of Chronic Stable Angina Part 1 DiPiro: Chapters 13 & 18: CV Testing and Acute Coronary Syndromes 1. ACC/AHA Guideline 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST- Segment Elevation Myocardial Infarction. Link found on course 2. AHA/ACC 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infraction. Link found on course Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST- Elevation Myocardial Infarction. Link found on course Feb. 9 (W) CV: Pharmacotherapy of Chronic Stable Angina Part 2 CV: Pharmacotherapy of Acute Coronary Syndromes Part 1 Feb. 10 (Th) Post-exam review of CV Exam 1 (optional) Feb. 11 (F) CV: Pharmacotherapy of Acute Coronary Syndromes Part 2 1. CHEST: Eighth ACCP Conference on Antithrombotic and Thrombolytic Therapy Link found on Course Many chapters will be helpful. 2. Guide to Anticoagulant Therapy: Heparin (AHA 2001 Scientific Statement). Link found on Course
3 DATE LECTURE TOPIC Feb. 14 (M) Feb. 16 (W) 3. AHA/ACC Foundation Guide to Warfarin Therapy (AHA 2003 Scientific Statement). Link found on Course CV: Clinical Use of AntiThrombotics in Cardiology CV: Acute Coronary Syndrome Case Review Quiz 3 (CSA and ACS) due by 8:00 am 02/15/10 CV: Introduction to Arrhythmias/Rhythm Recognition CV: Guidelines for the Management of Supraventricular Arrhythmias Required Readings: DiPiro: Chapter 19: Arrhythmias 1. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Link found on Course 2. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation. Link found on course 3. Antithrombotic therapy in atrial fibrillation. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:546S- 592S. Feb. 17 (Th) Pre-exam review for CV Exam #2 (optional) Dr. Schullo-Fuelner Feb. 18 (F) CV Exam #2 Dr. Schullo-Fuelner Feb. 21 (M) Feb. 23 (W) CV: Therapy of Supraventricular Arrhythmias CV: Therapy of Ventricular Arrhythmias CV: ACLS Algorithms part 1: VT/VF and Asystole/PEA CV: ACLS Algorithms part 2: Bradyarrhythmias/Tachyarrhythmias DiPiro: Chapter 14: Cardiopulmonary Arrest American Heart Association Guidelines for the Management of Cardiopulmonary Resuscitation and Emergency Cardiac Care Part 7.3: Management of Bradycardia and Tachycardia. Link found on Course Feb. 25 (F) American Heart Association Guidelines for the Management of Cardiopulmonary Resuscitation and Emergency Cardiac Care Part 7.2: Management of Cardiac Arrest. Link found on course CV: Introduction to cardiac hemodynamics and heart failure DiPiro: Chapter 16: Heart Failure
4 DATE LECTURE TOPIC Chapter 20: Diastolic Heart Failure (pages ) 1. DiPiro: Chapter 20: Diastolic Heart Failure (pages ) 2. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. Link found on course Post-exam review of CV Exam #2 (optional) Feb. 28 (M) CV: Pharmacotherapy of HF-I CV: Pharmacotherapy of HF-II Quiz 4 (Arrhythmias) due by 8:00 am 3/01/10 Mar. 2 (W) CV: Treatment of Acute HF-I CV: Treatment of Acute HF-II Mar. 4 (F) CV: HF/Arrhythmia review Mar. 7 (M) CV: Arrhythmia and HF cases Quiz 5 (HF management) due by 8:00 am 3/8/10 Mar. 9 (W) CV: DVT/PE-1 CV: DVT/PE-2 DiPiro: Chapter 21 : Venous Thromboembolism CHEST: Eighth ACCP Conference on Antithrombotic and Thrombolytic Therapy Prevention of Venous Thromboembolism and Antithrombotic Therapy for Venous Thromboembolic Disease. Link found on Mar. 10 (Th) Pre-exam review for CV Exam #3 (optional) Mar. 11 (F) CV Exam #3 Mar. 14 Mar. 16 Mar. 18 Mar. 21 (M) SPRING BREAK SPRING BREAK SPRING BREAK Endocrine: Orientation & Diabetes ADA Summary Guidelines 2011 (citation tba) ACCORD & ADVANCE trials DiPiro: Chapter 77: Diabetes Mellitus
5 Mar. 23 (W) Endocrine: Diabetes Mar. 24 (Th) Post exam review of CV Exam #3 (optional) Mar. 25 (F) Endocrine: Diabetes Small Group Case Discussion Multiple Multiple Mar. 28 (M) Endocrine: Diabetes AACE/ADA Consensus Statement - Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control. Endocrine Practice vol 15 No. 4 May/June 2009; 1-11 Dr. Skaar Mar. 30 (W) QUIZ 1 (Diabetes) due by 8:00 am 3/29/10 Endocrine: Diabetes Wrap-up and Cases Endocrine: Adrenal Therapeutics DiPiro: Chapter 79: Adrenal Gland Disorders Mar. 31 (Th) Pre-exam review for Endocrine Exam #1 (optional) Apr. 1 (F) Endocrine Exam #1 (all diabetes material) Apr. 4 (M) Apr. 6 (W) Endocrine: Thyroid Disorders DiPiro: Chapter 78: Thyroid Disorders Endocrine: Menopause/HRT DiPiro: Chapter 85: Hormone Therapy in Women QUIZ 2 (content from 3/30 to 4/6) due by 8:00 am 4/7/10 Apr. 8 (F) Endocrine: Drugs in Pregnancy and Lactation DiPiro: Chapter 81 Pregnancy and Lactation: Therapeutic Considerations (pgs , ) Apr. 11 (M) Post exam review for Endo Exam #1 (optional) Endocrine: Hormonal Contraception DiPiro: Chapter 82: Contraception Dr. Harris
6 Apr. 13 (W) Gastrointestinal: GERD DiPiro: Chapter 34: Gastroesophageal Reflux Disease Apr. 14 (Th) Pre-exam review for Endocrine Exam #2 (optional) Apr. 15 (F) Endocrine Exam #2 (material from 3/30-4/11) Apr. 18 (M) Gastrointestinal: Treatment of PUD DiPiro: Chapter 35: Peptic Ulcer Disease (in ) Apr. 20 (W) Mock Oral Exam Apr. 21 (Th) Apr. 22 (F) Apr. 25 (M) Post exam review of Endocrine Exam #2 (optional) Gastrointestinal: Exam #1 (material from 4/13 & 4/18) Gastrointestinal: Inflammatory Bowel Disease (IBD) DiPiro: Chapter 36: Inflammatory Bowel Disease (in ) Apr. 27 (W) Gastrointestinal: Drug-Induced Hepatic Disease DiPiro: Chapter 40: Drug-Induced Liver Disease Stress Ulcers DiPiro: Chapter 35: Peptic Ulcer Disease Optional: Post-exam review of GI exam #1 (TC only) 12:15-1:15 Location: 7-193/195 **Apr. 28 (TH)* ORAL EXAM Multiple Multiple Apr. 29 (F) May 2 (M) PHARMACY DAY!!! Gastrointestinal: Viral Hepatitis DiPiro: Chapter 42: Viral Hepatitis Optional: Post-exam review of GI exam #1 ( only) 12:15-1:15 Location: LSci 163 (in ) May 4 (W) Gastrointestinal: Diarrhea & Constipation DiPiro: Chapter 38: Diarrhea, Constipation (and Irritable Bowel Syndrome - NOT required) May 6 (F) May 9-13 Final Exam Week Gastrointestinal: Exam #2 (material from 4/25-5/4) Phar 6122 Comprehensive Final Written Exam 3 hours All
Pharmacotherapy Handbook
Pharmacotherapy Handbook Eighth Edition Barbara G. Wells, PharmD, HP, FCCP, BCPP Dean and Professor Executive Director, Research Institute of Pharmaceutical Sciences School of Pharmacy, The University
Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003
Authorized By: Medical Management Guideline Committee Approval Date: 12/13/01 Revision Date: 12/11/03 Beta-Blockers Nitrates Calcium Channel Blockers MEDICATIONS Indicated in post-mi, unstable angina,
Core Curriculum for the Cardiovascular Clinician
September 14 17, 2016 Heart House Washington, DC AGENDA Wednesday, September 14 PHARMACOLOGY WORKSHOP 5:30 p.m. Registration and Light Refreshments 6:00 p.m. Welcome and Introductions 6:15 p.m. CVD Guideline-driven
Conflicts of Interest: None. Aspirin, primary prevention and USPSTF. Primary prevention of ASCVD is important
Aspirin, primary prevention and USPSTF Presented by: Craig Williams, PharmD., BCPS., FNLA; February 2017 Conflicts of Interest: None Primary prevention of ASCVD is important Myocardial Infarction Incidence
Barbara G. Wells, PharmD, FASHP, FCCP, BCPP Dean and Professor School of Pharmacy, The University of Mississippi Oxford, Mississippi
Barbara G. Wells, PharmD, FASHP, FCCP, BCPP Dean and Professor School of Pharmacy, The University of Mississippi Oxford, Mississippi Joseph T. DiPiro, PharmD, FCCP Panoz Professor of Pharmacy, College
Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)
Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for Artery, Atrial Fibrillation, Hypertension
Drs. Rottman, Salloum, Campbell, Muldowney, Hong, Bagai, Kronenberg
Rotation: or: Faculty: Coronary Care Unit (CVICU) Dr. Jeff Rottman Drs. Rottman, Salloum, Campbell, Muldowney, Hong, Bagai, Kronenberg Duty Hours: Mon Fri, 7 AM to 7 PM, weekend call shared with consult
1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown
Medical-Surgical Nursing Care Second Edition Karen Burke Priscilla LeMone Elaine Mohn-Brown Chapter 26 Caring for Clients with Coronary Heart Disease and Dysrhythmias Coronary Heart Disease (CHD) Leading
Educational Goals and Objectives for Rotations on: Cardio Inpatient
Educational Goals and Objectives for Rotations on: Cardio Inpatient Residents will rotate through cardiology inpatient rotations to: Develop skills to evaluate and manage patients with diseases of the
Endocrinolgy. 4 th class
Medicine Curriculum for 4 th Year Med Students Hawler Medical University College of Medicine Department of Medicine Curriculum of 4 th class Subject Class : Endocrinolgy 4 th class Number of hours needed
Incorporated Dosing Guidelines: Intravenous Heparin Therapy Initial Dose
Intravenous Heparin Therapy Initial Dose (Max Dose) IV Infusion Rate IV Infusion Rate (Max Dose) Lab Tests High Dose 80 units/kg 8,000 units 18 units/kg/hr 1,800 units/hr Intermediate Dose 5,000 units
Instruct patient and caregivers: Need for constant monitoring Potential complications of drug therapy
Assessment Prior to administration: Assess patient for chest pain, dysrhythmias, and vital signs (initially and throughout therapy) Obtain complete medical history, including allergies, especially heart
LAC-USC Cardiology Consult Service
LAC-USC Cardiology Consult Service RESIDENT ORIENTATION First Day of Rotation: Report to 1 st day at LAC + USC Hospital 4 th floor Cardiology units Page Fellow day before rotation for more information
ARRHYTHMIAS AND DEVICE THERAPY
Topic List A BASICS 1 History of Cardiology 2 Clinical Skills 2.1 History Taking 2.2 Physical Examination 2.3 Electrocardiography 2.99 Clinical Skills - Other B IMAGING 3 Imaging 3.1 Echocardiography 3.2
Preliminary Programme
Preliminary Programme The scientific programme comprises various styles of presentations and sessions, each offering a unique opportunity to amass new and important scientific information. Optimal management
BIOL 266: Human Anatomy & Physiology II Spring 2017; MWF 1:30 2:20pm, Newton 203
BIOL 266: Human Anatomy & Physiology II Spring 2017; MWF 1:30 2:20pm, Newton 203 Course Objectives: This course is designed to provide an introduction to the anatomy and physiology of the human body. It
Common Codes for ICD-10
Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified
Pharmacology 260 Online Course Schedule Summer 2015
Pharmacology 260 Online Course Summer 201 The topics listed below do not necessarily correspond to a 1 - hour lecture period. You should cover the topics for each week at some time during that week. Readings
Mayo Clinic Physician Assistant Board Review
PHARMACOLOGY CONTENT Mayo Clinic Physician Assistant Board Review Select presentations will contain pharmacology content as noted in the program. Identified presentations represent approximately 11.75
Leslie Dan Faculty of Pharmacy University of Toronto. Course Outline and Syllabus ( )
Leslie Dan Faculty of Pharmacy University of Toronto Course Outline and Syllabus (2012 2013) Name: Professor Reina Bendayan Course Number: PHM143H1 Course Title: Pathobiology and Pathology Course Description:
Antithrombotics 201: Aspirin and USPSTF. Presented by: Craig Williams, PharmD., BCPS., FNLA; November, Conflicts of Interest: None
Antithrombotics 201: Aspirin and USPSTF Presented by: Craig Williams, PharmD., BCPS., FNLA; November, 2016 Conflicts of Interest: None 1 What percent of patients who die within 30 days of an MI die before
CuRe PreClerkship Presentation. CARDIOVASCULAR COURSE Anita Soni MD FRCP (C) January 23, 2014
CuRe PreClerkship Presentation CARDIOVASCULAR COURSE Anita Soni MD FRCP (C) January 23, 2014 DRAFT 5 Nov 1, 2013 Y1 M1 Y2 M2 CuRe Preclerkship M0, 1/2: Human Biology, Health and Human Disease Biology and
Cardiovascular and Pulmonary System
Cardiovascular and Pulmonary System MS1 - COM 531 - Spring 2018 3/21/2018 Weeks Date Time Title Faculty Monday, 3/26/2018 8:00-9:00 am CVP Course Introduction Falck & Yarbrough Monday, 3/26/2018 9:00-10:00
Leslie Dan Faculty of Pharmacy University of Toronto. Course Outline and Syllabus ( )
Leslie Dan Faculty of Pharmacy University of Toronto Course Outline and Syllabus (2017 2018) Course Instructor: Dr. Reina Course Number: PHM143H1 Course Title: Pathobiology and Pathology Course Description:
ECG Analysis and Interpretation Course Table of Contents:
ECG Analysis and Interpretation Course Table of Contents: Course Outline Overview/Rationale Aims of the Unit Objectives Content Teaching and Learning Methods Assessment Procedures Resources/Mode of Delivery
Atrial Fibrillation and the NOAC s. John Raymond MS, PA-C, MHP February 10, 2018
Atrial Fibrillation and the NOAC s John Raymond MS, PA-C, MHP February 10, 2018 Pathogenesis EPIDEMIOLOGY Arrhythmia-related hospitalisations in the US Ventricular fibrillation 2% Atrial fibrillation 34%
Phar 6754 Diabetes and Metabolic Syndrome
Phar 6754 Diabetes and Metabolic Syndrome Course Syllabus Spring 2019 2.1 Credits January 16 March 15, 2019 This course adheres to the items listed in the College of Pharmacy Central Syllabus: https://docs.google.com/a/umn.edu/document/d/1artq5e1rbzxe8letwo7be8k8snzaegmmz_qcw8yj-ii/edit?pli=1
Summary of Research and Writing Activities In Cardiovascular Disease
Summary of Research and Writing Activities In Cardiovascular Disease Carole Alison Chrvala, PhD 919.545.2149 (Work) 919.951.5230 (Mobile) cchrvala@centurylink.net www.healthmattersmedwriting.com 1 Manuscripts
XXI Congress of the Cardiology Society of Serbia (CSS) Preliminary Programme Zlatibor, October, 2017
XXI Congress of the Cardiology Society of Serbia () Preliminary Programme Zlatibor, 19-22 October, 15.00 Interventional Cardiology in Serbia 15.15 15.30 15.45 16.00 16.15 at the Congress Thursday, October
Hanna K. Al-Makhamreh, M.D., FACC Interventional Cardiologist
Hanna K. Al-Makhamreh, M.D., FACC Interventional Cardiologist Introduction. Basic Life Support (BLS). Advanced Cardiac Life Support (ACLS). Cardiovascular diseases (CVDs) are the number one cause of death
4:30 p.m. Jack Vogel Memorial Lecture Evolution and Revolution in the Treatment of Valvular Heart Disease Dr. Mack
AGENDA Friday, January 12 4:30 p.m. Registration at Westin Snowmass Conference Center 6:30 p.m. Saturday, January 13 3:30 p.m. Registration and Refreshment Break SESSION I Moderator: 4:00 p.m. Welcome
BIOL 439: Endocrinology
1 Biol 439-01 (Call # 15034) Michael Chen, Ph.D. Biol Sci 247 (323) 343-2084 MW 4:20-6:00 pm Biol Sci. 120 mchen@calstatela.edu Office hours: TWR: 2:00-4:00 pm BIOL 439: Endocrinology This course provides
Consensus Core Set: Cardiovascular Measures Version 1.0
Consensus Core Set: Cardiovascular s NQF 0330 Hospital 30-day, all-cause, riskstandardized readmission rate (RSRR) following heart failure hospitalization 0229 Hospital 30-day, all-cause, riskstandardized
Leslie Dan Faculty of Pharmacy University of Toronto. Course Outline and Syllabus ( )
Leslie Dan Faculty of Pharmacy University of Toronto Course Outline and Syllabus (2015 2016) Name: Dr. Reina Bendayan Course Number: PHM143H1 Course Title: Pathobiology and Pathology Course Description:
NurseAchieve. CHAPTERS INCLUDED IN THE NURSEACHIEVE COMPREHENSIVE NCLEX REVIEW NURSING SKILLS AND FUNDAMENTALS:
NurseAchieve www.nurseachieve.com CHAPTERS INCLUDED IN THE NURSEACHIEVE COMPREHENSIVE NCLEX REVIEW NCLEX TEST STRATEGIES: NCLEX EXAM OVERVIEW TEST TAKING STRATEGIES NURSING SKILLS AND FUNDAMENTALS: ADMINISTRATION
CVD Outcomes Aggregate Report Report Period: 05/01/ /30/2004
Changes in JNC VII Blood Pressure Categories Blood Pressure Category Initial Value ¹ Latest Value ¹ Improvement ² (Based on JNC VII Guidelines) values (days) (N=271) (N = 209) Normal (SBP < 120 and DBP
John Papadopoulos David R. Schwartz Consulting Editor. Pocket Guide to Critical Care Pharmacotherapy Second Edition
John Papadopoulos David R. Schwartz Consulting Editor Pocket Guide to Critical Care Pharmacotherapy Second Edition 123 Pocket Guide to Critical Care Pharmacotherapy John Papadopoulos Author David R. Schwartz
TYPE II MI. KC ACDIS LOCAL CHAPTER March 8, 2016
TYPE II MI KC ACDIS LOCAL CHAPTER March 8, 2016 TYPE 2 MI DEFINITION: Acute coronary syndrome (ACS) encompasses a continuum of myocardial ischemia and infarction, which can make the diagnostic and coding
Lahey Clinic Internal Medicine Residency Program: Curriculum for Cardiovascular Medicine Rotation
Lahey Clinic Internal Medicine Residency Program: Curriculum for Cardiovascular Medicine Rotation Faculty representative: David Venesy, MD Resident representative: David Kahan, MD Revision date: June 29,
University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CCU Rotation Goals and Objectives Goals
Goals Learn to coordinate a variety of data from multiple cardiovascular sub-disciplines, e.g. catheterization laboratory, hemodynamic study, non-invasive imaging, nuclear, electrophysiologic, and in combination
Title: Low Molecular Weight Heparins (LMWH), fondaparinux (Arixtra)
Origination: 03/29/05 Revised: 09/01/10 Annual Review: 11/20/13 Purpose: To provide guidelines and criteria for the review and decision determination of requests for medications that requires prior authorization.
Pharmacy Prep. Qualifying Pharmacy Review
Pharmacy Prep 2014 Misbah Biabani, Ph.D Director, Tips Review Centres 5460 Yonge St. Suites 209 & 210 Toronto ON M2N 6K7, Canada Luay Petros, R.Ph Pharmacy Manager, Wal-Mart, Canada 1 Disclaimer Your use
WOMEN S HEALTH FOR PRIMARY CARE. San Diego, California Hotel del Coronado August 10 13, 2017
WOMEN S HEALTH FOR PRIMARY CARE San Diego, California Hotel del Coronado August 10 13, 2017 Thursday, August 10th: 7:30 am 8:00 am Registration and Hot Breakfast 8:00 am 9:00 am Gynecology Abnormal Uterine
Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set
Unless indicated, the PINNACLE Registry measures are endorsed by the American College of Cardiology Foundation and the American Heart Association and may be used for purposes of health care insurance payer
Drug Class Monograph
Drug Class Monograph Class: Oral Anticoagulants Drug: Coumadin (warfarin), Eliquis (apixaban), Pradaxa (dabigatran), Savaysa (edoxaban), arelto (rivaroxaban) Formulary Medications: Eliquis (apixaban),
Asthma J45.20 Mild, uncomplicated J45.21 Mild, with (acute) exacerbation J45.22 Mild, with status asthmaticus
A Fib & Flutter I48.0 Paroxysmal atrial fibrillation I48.1 Persistent atrial fibrillation I48.2 Chronic atrial fibrillation I48.3 Typical atrial flutter Asthma J45.20 Mild, uncomplicated J45.21 Mild, with
Updates in Therapeutics: 2013 Pharmacotherapy Preparatory Review and Recertification Course
AMERICAN COLLEGE OF CLINICAL PHARMACY Updates in Therapeutics: 2013 Pharmacotherapy Preparatory Review and Recertification Course POSTTEST ANSWERS SESSION 8 Cardiology I 1. Answer B: NTG intravenously
CV Update Guidelines & Debates Royal Pharmaceutical Society, Great Britain Barnet 27/01/09
CV Update Guidelines & Debates Royal Pharmaceutical Society, Great Britain Barnet 27/01/09 Dr Ameet Bakhai, FRCP Cardiologist, Clinical Trials, Health Economics Barnet & Chase Farm NHS Trust Royal Free
Adrenaline 1mg in 10mL (1:10,000) Pre-filled syringe 3 Amiodarone 300mg/10mL Pre-filled syringe 5
Quick Reference Guide for: Cardiac Arrest Medicines Box (BLUE) Please Note: Any medicines given must form part of an Airway, Breathing, Circulation, Disability and Exposure (ABCDE) Assessment (9)999 must
3/23/2017. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate Europace Oct;14(10): Epub 2012 Aug 24.
Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Explain the efficacy and safety of triple therapy, in regards to thromboembolic and bleeding risk Summarize the guideline recommendations
Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017
Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Explain the efficacy and safety of triple therapy, in regards to thromboembolic and bleeding risk Summarize the guideline recommendations
Evolve180 / Ideal Northwest Health Profile
Evolve180 / Ideal Northwest Health Profile ABOUT YOU First Name: Last Name: Address: City: State: Zip: Phone: Email: Date of Birth: Age: Height: Occupation: How did you find out about our program? Marital
Hypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to
Hypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to 90 mmhg. These pressures are called Normal blood pressure
Treatment of the Medically Compromised Patient
Treatment of the Medically Compromised Patient Nashville Area Continuing Dental Education Series November 3, 2010 Harry J. Brown, MD Chief Medical Officer, Nashville Area Outline General Principles Specific
A DAYS CARDIOVASCULAR UNIT GUIDE DUE WEDNESDAY 4/12
A DAYS CARDIOVASCULAR UNIT GUIDE DUE WEDNESDAY 4/12 MONDAY TUESDAY WEDNESDAY THURSDAY FRIDAY 3/20 - B 3/21 - A 3/22 - B 3/23 - A 3/24 - B 3/27 - A Dissection Ethics Debate 3/28 - B 3/29 - A Intro to Cardiovascular
AF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management
AF in the ER: Common Scenarios Atrial fibrillation is a common problem with a wide spectrum of presentations. Below are five common emergency room scenarios and the management strategies for each. Evan
Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name
Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for, Atrial Fibrillation, Hypertension and.
2015 Preliminary Agenda
2015 Preliminary Agenda Revised 10/08/15 THURSDAY, NOVEMBER 12, 2015 PRE-COURSE WORKSHOP LEARNING OBJECTIVES: At the conclusion of this activity, participants will be better able to: 1. Identify subtle
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
Controversies in Cardiac Pharmacology
Controversies in Cardiac Pharmacology Thomas D. Conley, MD FACC FSCAI Disclosures I have no relevant relationships with commercial interests to disclose. 1 Doc, do I really need to take all these medicines?
Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2
10/2013 1 Objectives Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2 Purpose of this Education Module: Chest Pain Center Accreditation involves
Objectives. Acute Coronary Syndromes; The Nuts and Bolts. Overview. Quick quiz.. How dose the plaque start?
Objectives Acute Coronary Syndromes; The Nuts and Bolts Michael P. Gulseth, Pharm. D., BCPS Pharmacotherapy II Spring 2006 Compare and contrast pathophysiology of unstable angina (UA), non-st segment elevation
2008, American Heart Association. All rights reserved.
AHA 2008 Cocaine-Associated Chest Pain and Myocardial Infarction Slide Set Based on the AHA 2008 Scientific Statement for Management of Cocaine-Associated Chest Pain and Myocardial Infarction George J.
Index. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acute coronary syndrome(s), anticoagulant therapy in, 706, 707 antiplatelet therapy in, 702 ß-blockers in, 703 cardiac biomarkers in,
Phase III Comm. 3 Lunch Break Lunch Break Lunch Break Lunch Break Lunch Break Lunch Break
Phase III Comm. 3 13-Nov-17 09.00-09.50 Study Hours Monday 10.00-10.50 Study Hours 11.00-11.50 Introduction to Autonomous Nervous system Pharmacology A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 12.00-12.50 Introduction
BIOBANQUE- AVAILABLE VARIABLES
BIOBANQUE- AVAILABLE VARIABLES DEM DEM-11 DEM-12 DEM-13 DEM-14 DEM-21 DEM-22 DEM-31 DEM-32 DEM-33 DEM-41 DEM-42 DEM-43 DEM-44 DEM-50 DEM-51 DEM-52 DEM-53 DEM-54 DEM-61 DEM-62 CVHX CVHX-11 CVHX-12 CVHX-13
Arrhythmia 341. Ahmad Hersi Professor of Cardiology KSU
Arrhythmia 341 Ahmad Hersi Professor of Cardiology KSU Objectives Epidemiology and Mechanisms of AF Evaluation of AF patients Classification of AF Treatment and Risk stratification of AF Identify other
An Overview of Perioperative Medicine 2014: From Outpatient Preoperative Assessment to Inpatient Postoperative Care
An Overview of Perioperative Medicine 2014: From Outpatient Preoperative Assessment to Inpatient Postoperative Care WEDNESDAY, OCTOBER 22, 2014 6:00 a.m. Continental Breakfast and Registration 7:30 a.m.
Major Clinical Practice Guidelines
Alzheimer's Disease/Dementia Anticoagulation Patients with Alzheimer's Disease and Other Dementias Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical
The subject is composed from theoretical lectures and clinical practicals.
Published on Second Faculty of Medicine, Charles University ( https://www.lf2.cuni.cz) Internal Medicine I Submitted by Marie Havlová on 28. August 2014-0:00 Syllabus of Internal Medicine I The subject
FastTest. You ve read the book now test yourself
FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. The answers will refer you back to
TAVI and Valve Replacement Thromboprophylaxis. Warren Prokopiw Pharmacy Resident
TAVI and Valve Replacement Thromboprophylaxis Warren Prokopiw Pharmacy Resident 2011-2012 Case Mr MW 76 yo Admitted 14 May for worsening CHF PMH: Aortic Stenosis, CVD (CABG x4 1980, PCI x3 stent 2008)
Evaluating Exam Review Book and Guide
Pharmacy Prep Evaluating Exam Review Book and Guide Misbah Biabani, Ph.D Director Toronto Institute of Pharmaceutical Sciences (TIPS) Inc. Toronto, ON M2N 6K7 Pharmacy Prep Professional Exams Preparation
Holy Crap! Why is a Cardiologist Speaking at a GI Meeting? Jonathan A. Rapp, MD, FACC, FSCAI Cardiologist, Mercy Heart Institute Cincinnati, OH
Holy Crap! Why is a Cardiologist Speaking at a GI Meeting? Jonathan A. Rapp, MD, FACC, FSCAI Cardiologist, Mercy Heart Institute Cincinnati, OH Goals and Objectives Discuss cardiac considerations for patients
Polypharmacy - arrhythmic risks in patients with heart failure
Influencing sudden cardiac death by pharmacotherapy Polypharmacy - arrhythmic risks in patients with heart failure Professor Dan Atar Head, Dept. of Cardiology Oslo University Hospital Ullevål Norway 27.8.2012
Acute Coronary Syndromes
Overview Acute Coronary Syndromes Rabeea Aboufakher, MD, FACC, FSCAI Section Chief of Cardiology Altru Health System Grand Forks, ND Epidemiology Pathophysiology Clinical features and diagnosis STEMI management
Chapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy
Chapter 9 Cardiac Arrhythmias Learning Objectives Define electrical therapy Explain why electrical therapy is preferred initial therapy over drug administration for cardiac arrest and some arrhythmias
Physiological Basis of Disease, Fall 2013 (3 Credits)
Physiological Basis of Disease, Fall 2013 (3 Credits) Mondays, 1:00 2:30 pm Thursdays, 1:00 2:30 pm Program 761 Course 600 Room: V14 Course Director: Huizhou Fan, Ph.D. Associate Professor Department of
Atrial Fibrillation. Why It s Important. Updated on 2007 / 11 / 23. Microlife Corp ww.microlife.com. Page 1
Atrial Fibrillation Why It s Important Microlife Corp ww.microlife.com Updated on 2007 / 11 / 23 Page 1 CONTENT ORIGINAL PRESENTATION P3 ~ P13 UPDATED ASH ABSTRACT SUBMISSION INFORMATION INTERESTING LINK
Coding Hints 2 nd Edition
Coding Hints 2 nd Edition Medicare s guidelines state, Code all documented conditions which co-exist at the time of the visit that require or affect patient care or treatment. Beyond the Basics Incomplete
DNH 120 Management of Emergencies
Revised: Spring 2016 DNH 120 of Emergencies COURSE OUTLINE Prerequisites: None Course Description: Studies the various medical emergencies and techniques for managing emergencies in the dental setting.
Cardiovascular Disorders Lecture 3 Coronar Artery Diseases
Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in
ASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS
ASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS O. Dalleur 1,4, B. Boland 2,3, A. Spinewine 4-5 1 Pharmacy and 2 Geriatric Medicine, St-Luc university Hospital, 3 Institute of
CONTENT OUTLINE FOR THE PHARMACOTHERAPY CERTIFICATION EXAMINATION
CONTENT OUTLINE FOR THE PHARMACOTHERAPY CERTIFICATION EXAMINATION The following domains, tasks and knowledge statements were delineated by the BPS Specialty Council on Pharmacotherapy and validated through
Principles of Medical Physiology
Principles of Medical Physiology Course Syllabus Course Number: Credit Hours: Course Format: GMS 6400C 6 credit hours This online course is tailored for asynchronous distance learners. COURSE DESCRIPTION
Course Title Systematic Pharmacology I
Course Code MED-308 Course Title Systematic Pharmacology I ECTS Credits 6 School Medical School Semester Spring (Semester 6) Prerequisites MED-303 Pharmacology Type of Course Field Language of Instruction
Atrial Fibrillation and Heart Failure: A Cause or a Consequence
Atrial Fibrillation and Heart Failure: A Cause or a Consequence Rajat Deo, MD, MTR Assistant Professor of Medicine Division of Cardiology, Electrophysiology Section University of Pennsylvania November
PA-1350: ELECTROCARDIOGRAPHY
PA-1350: Electrocardiography 1 PA-1350: ELECTROCARDIOGRAPHY Cuyahoga Community College Viewing:PA-1350 : Electrocardiography Board of Trustees: 2015-05-28 Academic Term: 2015-08-24 Subject Code PA - Physician
Cardiovascular Diseases and Diabetes
Cardiovascular Diseases and Diabetes LEARNING OBJECTIVES Ø Identify the components of the cardiovascular system and the various types of cardiovascular disease Ø Discuss ways of promoting cardiovascular
Clinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!!
Clinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!! Abha'Khandelwal,'MD,'MS' 'Stanford'University'School'of'Medicine'
Clinical Practice Guideline
Clinical Practice Guideline Secondary Prevention for Patients with Coronary and Other Vascular Disease Since the 2001 update of the American Heart Association (AHA)/American College of Cardiology (ACC)
Overview of Current Quality Measures that can be Impacted by Ambulatory Pharmacists
Overview of Current Quality Measures that can be Impacted by Ambulatory Pharmacists Measure Name Measure Domain Measure Focus Comment/Explanation CMS Value-based Purchasing Program (CMS VBP) AMI 30-day
Chest Pain. Dr. Amitesh Aggarwal. Department of Medicine
Chest Pain Dr. Amitesh Aggarwal Department of Medicine BACKGROUND Approx 5% of all ED visits 15 % - AMI 25-30 % - Unstable angina 50-55 % - Other conditions Atypical presentations common 2% of patients
Cardiac arrhythmias in the PICU
Cardiac arrhythmias in the PICU Paolo Biban, MD Director, Neonatal and Paediatric Intensive Care Unit Division of Paediatrics, Major City Hospital Azienda Ospedaliera Universitaria Integrata Verona, Italy
Practice-Level Executive Summary Report
PINNACLE Registry Metrics 0003, Test Practice_NextGen [Rolling: 1st April 2015 to 31st March 2016 ] Generated on 5/11/2016 11:37:35 AM American College of Cardiology Foundation National Cardiovascular
Acute Coronary Syndrome (ACS) Initial Evaluation and Management
Acute Coronary Syndrome (ACS) Initial Evaluation and Management Symptoms of Possible ACS Chest discomfort with or without radiation to the arm(s), jaw, or epigastrium Short of breath Weakness Diaphoresis
Nitroglycerin and Heparin Drip Interfacility Protocols
Nitroglycerin and Heparin Drip Interfacility Protocols EMS Protocol This protocol applies to nitroglycerin and Heparin drips that are initiated at the transferring facility prior to transport and are not
American Heart Association Guidelines For Cardiopulmonary Resuscitation And Emergency Cardiovascular Care
American Heart Association Guidelines For Cardiopulmonary Resuscitation And Emergency Cardiovascular Care AMERICAN HEART ASSOCIATION GUIDELINES FOR CARDIOPULMONARY RESUSCITATION AND EMERGENCY CARDIOVASCULAR
Speaker Disclosure. Pharmacist Objectives. Path to New Hypertension (HTN) Guidelines. Overview of New HTN Guidelines 8/21/2014
Speaker Disclosure Erica Pearce, Pharm.D. declares no conflicts of interest, real or apparent, and no financial interests in any company, product, or service mentioned in this program, including grants,
Measure Owner Designation. AMA-PCPI/NCQA (contract) is the measure owner. AMA-PCPI is the measure owner. AMA-PCPI/ASCO/NCCN is the measure owner
2012 EHR Measure Specifications The specifications listed in this document have been updated to reflect clinical practice guidelines and applicable health informatics standards that are the most current